Treponemal antibody tests are essential to the diagnosis of syphilis and other treponematoses. Accordingly, a number of Treponema pallidum test reagents and procedures have been developed. Live T. pallidum organisms are used as an antigen in immobilization tests, acetone-fixed whole organisms are used in indirect immunofluorescence tests, and lysates of T. pallidum adsorbed to or coupled with erythrocytes are used in indirect hemagglutination tests. Recently, the use of lysates in experimental radioimmunoassays and enzyme-linked immunosorbent assays has been reported (13, 17) .
After numerous studies and evaluations, a third-generation indirect immunofluorescence test, the fluorescent treponemal antibody absorption (FTA-ABS) procedure, has been acknowledged as the standard diagnostic technique with which other procedures are compared (5, 7, 12) . Two hemagglutination procedures, the microhemagglutination T. pallidum test and the hemagglutination treponemal test for syphilis, have been recognized by the Centers for Disease Control as provisional techniques; these are also used in diagnostic laboratories (11, 15, 19 instability of reagents, and the subjectivity of test readings. The complexities of the FTA-ABS test render the procedure unsuitable for smaller laboratories and invite modifications detrimental to good laboratory practice (1, 9) . T. pallidum hemagglutination test reagents are relatively unstable. Diluted erythrocyte reagents for the microhemagglutination T. pallidum test and hemagglutination treponemal test for syphilis are useful for only 1 to 3 days (3, 14, 19) . Estimates of the extent of T. pallidum fluorescence or of erythrocyte aggregation are subject to a number of variables, especially with specimens containing the minimum ("borderline") antibody concentration (9, 15 with TBS or 0.85% saline at dilutions greater than 1:640, the plots of the AFSU versus the equivalent titer were nonlinear: the AFSUs were less than would be predicted by the FTA titer. However, the same titrations with NSP diluent were linear. Therefore, to establish calibrator curves with serum dilutions greater than 1:640, dilutions were made in NSP.
The amount of T. pallidum lysate to be fixed on the disks was determined by block titrations and calibrator curve comparisons with syphilis sera and NSP. The slopes of calibrator curves made with different antigen preparations were the same. At the antigen optimum, the syphilis sera showed the maximum AFSU; the normal sera showed the minimum AFSU. For the study, 1 to 2 pl of lysate derived from 5 x 109 T. pallidum organisms per ml was used.
Results of SFTA tests with sera from patients with syphilis, sera from presumed normal individuals, and ART-false-positive sera are summarized in Table 1 . The SFTA unequivocally separated sera containing treponemal antibody from FTA-ABS-nonreactive sera. In the first series with antigen lot 091, the minimum AFSU obtained with reactive sera (late latent disease) was 64, and the maximum /FSU with normal sera was 37, a difference of 27 U. The corresponding difference in the second series was 21 U (primary disease, 67; normal sera, 46). Further, the minimum mean AFSUs of reactive sera (87 for late latent sera in the first series, 113 for primary and late latent sera in the second series) were more than three times those of the normal sera (27 and 35, respectively) in each series. The reproducibility of the SFTA was high with sera containing relatively high or low concentrations of treponemal antibody, as well as with sera presumably containing no antibody (Table 2) .
Results obtained with one set of calibrators and a single T. pallidum antigen preparation were consistent over a 6-month test period. The mean AFSU and coefficient of variation (CV) for six determinations, three made on day 1 and three on day 189, were: high calibrator (titer, 3,200), mean of 159.3 and CV of 7.3%; low calibrator (titer, 200), mean of 85.3 and CV of 4.3%; and NSP diluent, mean of 44.4 and CV of 3.3%. Similar values were obtained at intervals between days 1 and 189. Thus, the two solidphase T. pallidum antigen lots were stable for at least 6 months.
DISCUSSION
The objective SFTA test is made possible by the T. pallidum lysate antigen adsorbed to a solid surface. The solid-phase antigen, its attachment to a plastic probe, and the SFTA protocol eliminate problems encountered with FTA-ABS tests (8) . In the SFTA, each antigenantibody reaction is isolated in a single test tube. Thus, mixing of specimens and transfer of antigen, with the possible consequence of erroneous results (as may happen with multiwell microscope slide tests), is avoided (9) . Also, since each antigen probe with serum antibody or antibody-conjugate complex is rinsed in a separate tube, contamination during the rinse steps is prevented, and the ratio of reactants to rinse fluid is constant for all specimens. SFTA antigen-antibody reactions are developed at room temperature by the motion of the mechanical shaker. In contrast, the FTA-ABS procedure relies on relatively weak Brownian movement and convection currents at an incubator temperature (37°C) to bring reactions to completion. There was complete agreement between the SFTA and FTA-ABS results based on the AFSU separation between normal and syphilis sera (Table 1) . To determine the exact AFSU cutoff value which will discriminate between specimens containing specific treponemal antibody and those without antibody, a minimally reactive calibrator serum (such as the FTA-ABS 1 + control serum established by the Centers for Disease Control) could be prepared. Specimens with a AFSU greater than that of this serum would be considered reactive; specimens with lower values would be considered nonreactive.
The excellent reproducibility of the SFTA is achieved in part because test fluorescence is presented as a digital meter reading. The risk of operator reading error is thus greatly reduced. The reproducibility is comparable to that of other fluoroimmunometric assays and is far greater than expected with existing serological techniques (2, 8, 16, 18) . The separation achieved between normal and treponemal antibody-containing sera and the precise data indicate that the discrimination of the SFTA is likely to exceed that of the subjective FTA-ABS test. The run-torun precision achieved with the low-calibrator sera (CV = 13.2%) and NSP controls (CV = 9.3%) indicates that SFTA results with minimally reactive sera are reproducible. Immunoglobulin class-specific fluoroscein isothiocyanate conjugate is used in the SFTA to avoid nonspecific reactions and minimally reactive results attributable to the anti-whole-globulin conjugate used in the FTA-ABS tests. FTA-ABS variability with minimally reactive (borderline) sera detected by anti-whole-globulin conjugate is exceptionally high, and reproducibility is difficult to achieve (6, 9, 10). Consequently, routine ETA-ABS results with borderline reactive sera correlate poorly with diagnoses of syphilis (1, 4, 15 
